ALT
Altimmune Inc
NASDAQ · Biotechnology
$4.87
-0.05 (-1.02%)
Open$5.00
Previous Close$4.92
Day High$5.09
Day Low$4.84
52W High$7.73
52W Low$2.90
Volume—
Avg Volume5.61M
Market Cap609.88M
P/E Ratio—
EPS$-1.07
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+116.6% upside
Current
$4.87
$4.87
Target
$10.55
$10.55
$6.68
$10.55 avg
$11.58
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 37.6K | 227.0K | 275.34M |
| Net Income | -167,659,958 | -911,745,995 | 25.15M |
| Profit Margin | -475,295.0% | -451,530.3% | 9.1% |
| EBITDA | -181,460,471 | -1,041,615,996 | 32.97M |
| Free Cash Flow | — | — | 15.51M |
| Rev Growth | -83.5% | -83.5% | +15.3% |
| Debt/Equity | — | — | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |